Anthony J. Dolisi
Corporate Officer/Principal chez GENEREX BIOTECHNOLOGY CORPORATION
Postes actifs de Anthony J. Dolisi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Corporate Officer/Principal | 08/01/2019 | - |
Olaregen Therapeutix, Inc.
 Olaregen Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Olaregen Therapeutix, Inc. develops and manufactures regenerative medicines. The firm offers Excellagen, a topically applied product for dermal wounds and other indications. The company was founded in 2017 and is headquartered in New York, NY. | Directeur Général | 01/01/2018 | - |
| President | 01/01/2018 | - |
Historique de carrière de Anthony J. Dolisi
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Executive Officer | 1 |
| President | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Olaregen Therapeutix, Inc.
Olaregen Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Olaregen Therapeutix, Inc. develops and manufactures regenerative medicines. The firm offers Excellagen, a topically applied product for dermal wounds and other indications. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
- Bourse
- Insiders
- Anthony J. Dolisi
- Expérience
